Development of the Composition and Manufacturing Technology of a New Combined Drug: Lavaflam
Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2018, Vol 15, Issue 3
Abstract
Objectives: Treatment of diseaes of the biliary system is one of the urgent problems of modern medicine. Materials and Methods: An original pharmaceutical drug “Lavaflam” in the form of combined tablets, which includes a composition of herbal components flamin (0.05 g) and lavender oil (0.02 g), was proposed for the complex treatment of diseases of the biliary system. Flamin is phytomedicine from the immortelle flowers [Helichrysum arenarium (L.) Moench, Asteraceae], which contains a complex of active substances from the flavonoids group (salipurposide, isosalipurposide, kaempferol, luteolin). It is applied as a choleretic and an anti-inflammatory agent in cholecystitis, cholangitis, and biliary dyskinesia. Tablets were prepared by pressing for separate granulation technology. Results: The lavender oil granulate was prepared using the solid phase method, and β-cyclodextrin was used as an excipient substance. The flamin granulate was prepared by mixing with the spherical-shaped filler mannitol PARTECK M 200. On the basis of previous studies, the excipients of the designed composition tablet “Lavaflam” were β-cyclodextrin (0.27 g), mannitol PARTECK M 200 (0.20 g), croscarmellose sodium (0.03 g), potato starch (0.022 g), PEG 6000 (0.002 g), and magnesium stearate (0.006 g). The assay of the main components of lavender oil with the references linalol and linalyl acetate was performed using gas chromatography. The assay of the total flavonoids of flamin was performed using spectrophotometry with isosalipurposide as the reference. Conclusion: The new phytomedicine tablets “Lavaflam” meet European Pharmacopoeia requirements on the following parameters: appearance, geometric size, average weight, disintegration, friability, resistance of tablets to crushing, and quantification.
Authors and Affiliations
Tanya IVKO, Milena ASLANIAN, Larisa BOBRYTSKA, Natalia POPOVA, Olena NAZAROVA, Tamara GERMANYUK
Keywords
Related Articles
- EP ID EP421229
- DOI 10.4274/tjps.79553
- Views 141
- Downloads 0
Phytochemical Screening and Toxicological Evaluation of Sargassum wightii Greville in Wistar Rats
Objectives: The present study was conducted to identify the phytoconstituents present in different extracts of Sargassum wightii and to assess the toxicity of its ethanol extract. Materials and Methods: Successive solven...
Establishment and Escalation of an Amino Acid Stacked Repressible Release Embedded System Using Quality by Design
Objectives: The traditional approach of developing a new delivery system is an exhaustive task and requires a number of resources like manpower, money, material, and time. To overcome this problem Quality by Design (QbD)...
Is There an Association Between Extreme Levels of Boron Exposure and Decrease in Y:X Sperm Ratio in Men? Results of an Epidemiological Study
Objectives: A negative association between Y:X sperm ratio and high levels of boron exposure was suggested in an epidemiological study conducted in boron mining areas of China. That study, however, was criticized by many...
Development and Validation of a High-performance Liquid Chromatography–Diode-array Detection Method for the Determination of Eight Phenolic Constituents in Extracts of Different Wine Species
Objectives: A new HPLC method was developed and validated for the determination of some phenolic compounds; gallic acid, chlorogenic acid, epigallocatechin, caffeic acid, vanillin, p-coumaric acid, rutin, and quercetin i...
A Review on: Phase ‘0’ Clinical Trials or Exploratory Investigational New Drug
In a move to speed up the development of new medicines, the Food and Drug Administration announced in January 2006 the creation of the exploratory Investigational New Drug (IND), the so-called phase ‘0’ clinical trials....